Molecular Formula | C9H8BrNO |
Molar Mass | 226.07 |
Density | 1.559±0.06 g/cm3(Predicted) |
Melting Point | 170-172℃ |
Boling Point | 376.3±42.0 °C(Predicted) |
Flash Point | 181.352°C |
Vapor Presure | 0mmHg at 25°C |
Appearance | Powder |
Color | Brown |
pKa | 13.92±0.20(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
Sensitive | Light Sensitive |
Refractive Index | 1.6 |
Hazard Symbols | Xn - Harmful |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R52 - Harmful to aquatic organisms R22 - Harmful if swallowed |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
application | 6-bromo -1,2,3, 4-tetrahydro-2-quinolinone can be used as an intermediate in organic synthesis and a pharmaceutical intermediate, mainly used in laboratory research and development and chemical production. |
preparation | 3, 4-dihydroquinoline -2(1H)-one (2.73g,18.55mmol) was dissolved in N,N-dimethylacetamide (30mL), and N-bromosuccinimide (3.30g) was slowly added in an ice water bath, 18.55mmol) of N,N-dimethylacetamide (10mL) solution. The reaction solution continued to be stirred in an ice water bath for 6 hours and then heated to room temperature for 12 hours. After the reaction, water (50mL) was added to the reaction mixture and extracted with ethyl acetate (50mL × 3). The organic phases were combined, dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate (v/v)= 3/1) to obtain a white solid (3.86g,92.1%). |